Literature DB >> 17963812

Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins.

Magnus Sundstrom1, Udayan Chatterji, Lana Schaffer, Sohela de Rozières, John H Elder.   

Abstract

Expression of the feline immunodeficiency virus (FIV) accessory protein OrfA (or Orf2) is critical for efficient viral replication in lymphocytes, both in vitro and in vivo. OrfA has been reported to exhibit functions in common with the human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) accessory proteins Vpr and Tat, although the function of OrfA has not been fully explained. Here, we use microarray analysis to characterize how OrfA modulates the gene expression profile of T-lymphocytes. The primary IL-2-dependent T-cell line 104-C1 was transduced to express OrfA. Functional expression of OrfA was demonstrated by trans complementation of the OrfA-defective clone, FIV-34TF10. OrfA-expressing cells had a slightly reduced cell proliferation rate but did not exhibit any significant alteration in cell cycle distribution. Reverse-transcribed RNA from cells expressing green fluorescent protein (GFP) or GFP+OrfA were hybridized to Affymetrix HU133 Plus 2.0 microarray chips representing more than 47,000 genome-wide transcripts. By using two statistical approaches, 461 (Rank Products) and 277 (ANOVA) genes were identified as modulated by OrfA expression. The functional relevance of the differentially expressed genes was explored by Ingenuity Pathway Analysis. The analyses revealed alterations in genes critical for RNA post-transcriptional modifications and protein ubiquitination as the two most significant functional outcomes of OrfA expression. In these two groups, several subunits of the spliceosome, cellular splicing factors and family members of the proteasome-ubiquitination system were identified. These findings provide novel information on the versatile function of OrfA during FIV infection and indicate a fine-tuning mechanism of the cellular environment by OrfA to facilitate efficient FIV replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963812      PMCID: PMC2255568          DOI: 10.1016/j.virol.2007.09.039

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.

Authors:  Riccardo Gavioli; Eleonora Gallerani; Cinzia Fortini; Marina Fabris; Arianna Bottoni; Alessandro Canella; Angela Bonaccorsi; Mauro Marastoni; Fabiola Micheletti; Aurelio Cafaro; Paola Rimessi; Antonella Caputo; Barbara Ensoli
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

2.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.

Authors:  P T Sillekens; R P Beijer; W J Habets; W J van Verooij
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

4.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest.

Authors:  Malou C Gemeniano; Earl T Sawai; Ellen E Sparger
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

6.  Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.

Authors:  Delphine Ropers; Lilia Ayadi; Renata Gattoni; Sandrine Jacquenet; Laurence Damier; Christiane Branlant; James Stévenin
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

7.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

9.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments.

Authors:  Rainer Breitling; Patrick Armengaud; Anna Amtmann; Pawel Herzyk
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

10.  cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins.

Authors:  P T Sillekens; W J Habets; R P Beijer; W J van Venrooij
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  13 in total

1.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

3.  Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Yang Hong; Cathy Wang; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

4.  Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Authors:  Magnus Sundstrom; Rebecca L White; Aymeric de Parseval; K Jagannadha Sastry; Garrett Morris; Chris K Grant; John H Elder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

Review 5.  FIV Gag: virus assembly and host-cell interactions.

Authors:  Benjamin G Luttge; Eric O Freed
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

6.  Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Authors:  Erika Assarsson; Jason A Greenbaum; Magnus Sundström; Lana Schaffer; Jennifer A Hammond; Valerie Pasquetto; Carla Oseroff; R Curtis Hendrickson; Elliot J Lefkowitz; David C Tscharke; John Sidney; Howard M Grey; Steven R Head; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

Review 7.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

8.  Construction and testing of orfA +/- FIV reporter viruses.

Authors:  Hind J Fadel; Dyana T Saenz; Eric M Poeschla
Journal:  Viruses       Date:  2012-01-23       Impact factor: 5.048

9.  RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region.

Authors:  Laurie James; Bruno Sargueil
Journal:  Nucleic Acids Res       Date:  2008-07-14       Impact factor: 16.971

10.  Transcriptional profiling of the host cell response to feline immunodeficiency virus infection.

Authors:  Reinhard Ertl; Dieter Klein
Journal:  Virol J       Date:  2014-03-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.